doi.org/10.1016/s1470-2045(21)00241-2

Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study

..., Regina Gironés Sarrió
11
The Lancet Oncology35.90
Volume: 22, Issue: 7, Pages: 946 - 958
Published: Jun 15, 2021
Paper Fields
Paper Details
Title
Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study
DOI
doi.org/10.1016/s1470-2045(21)00241-2
Published Date
Jun 15, 2021
Journal
The Lancet Oncology
Volume
22
Issue
7
Pages
946 - 958
© 2025 Pluto Labs All rights reserved.